Microarrays bring new insights into understanding of breast cancer metastasis to bone
- PMID: 14979907
- PMCID: PMC400646
- DOI: 10.1186/bcr736
Microarrays bring new insights into understanding of breast cancer metastasis to bone
Abstract
Using a microarray approach, Kang and colleagues identified several genes involved in the generation of breast cancer metastasis in bone and demonstrated their roles in bone colonization in vivo. Their findings and interpretations are reviewed in the context of recent array studies that compared gene expression in primary tumors and metastases. RNA expression array results have already demonstrated value in predicting whether metastases will develop in patients. They have also shown that expression patterns are similar in primary tumors and metastases. The latter data have invited re-examination of long-held notions related to mechanisms of metastasis. While the arrays show promise for improving diagnostic capability in breast cancers, ascribing mechanistic interpretations to correlative data should be done with extreme caution. Kang and colleagues' paper in Cancer Cell elegantly reinforces the concepts that efficiency of the metastatic process is dependent on the coordinated expression of multiple genes and that the expression of metastasis-associated genes is sometimes dependent on the microenvironment in which cells find themselves.
Similar articles
-
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs.J Bone Miner Res. 2012 Nov;27(11):2387-98. doi: 10.1002/jbmr.1686. J Bone Miner Res. 2012. PMID: 22714395
-
Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study.Breast Cancer Res. 2017 Oct 13;19(1):113. doi: 10.1186/s13058-017-0881-y. Breast Cancer Res. 2017. PMID: 29029636 Free PMC article.
-
Identification of genes potentially involved in bone metastasis by genome-wide gene expression profile analysis of non-small cell lung cancer in mice.Int J Oncol. 2012 May;40(5):1455-69. doi: 10.3892/ijo.2012.1348. Epub 2012 Jan 27. Int J Oncol. 2012. PMID: 22294041
-
Multistep tumorigenesis and the microenvironment.Breast Cancer Res. 2004;6(2):93-101. doi: 10.1186/bcr772. Epub 2004 Feb 12. Breast Cancer Res. 2004. PMID: 14979914 Free PMC article. Review.
-
Using microarray analysis as a prognostic and predictive tool in oncology: focus on breast cancer and normal tissue toxicity.Semin Radiat Oncol. 2008 Apr;18(2):105-14. doi: 10.1016/j.semradonc.2007.10.007. Semin Radiat Oncol. 2008. PMID: 18314065 Review.
Cited by
-
Application of microarray in breast cancer: An overview.J Pharm Bioallied Sci. 2012 Jan;4(1):21-6. doi: 10.4103/0975-7406.92726. J Pharm Bioallied Sci. 2012. PMID: 22368395 Free PMC article.
-
The Breast Cancer to Bone (B2B) Metastases Research Program: a multi-disciplinary investigation of bone metastases from breast cancer.BMC Cancer. 2015 Jul 10;15:512. doi: 10.1186/s12885-015-1528-y. BMC Cancer. 2015. PMID: 26156521 Free PMC article.
-
Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.Oncol Lett. 2017 Jan;13(1):488-496. doi: 10.3892/ol.2016.5438. Epub 2016 Nov 28. Oncol Lett. 2017. PMID: 28123587 Free PMC article.
-
New therapeutic targets for cancer bone metastasis.Trends Pharmacol Sci. 2015 Jun;36(6):360-73. doi: 10.1016/j.tips.2015.04.006. Epub 2015 May 9. Trends Pharmacol Sci. 2015. PMID: 25962679 Free PMC article. Review.
-
Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy.Acad Radiol. 2007 Apr;14(4):398-405. doi: 10.1016/j.acra.2007.01.005. Acad Radiol. 2007. PMID: 17368207 Free PMC article. Review.
References
-
- Kang YB, Siegel PM, Shu WP, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537–549. - PubMed
-
- Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571–573. - PubMed
-
- Perou CM, Sorlie T, Eisen MB, Van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Aksien LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. doi: 10.1038/35021093. - DOI - PubMed
-
- Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA. 2001;98:10869–10874. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
-
- Van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530–536. doi: 10.1038/415530a. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical